Cargando…

Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

BACKGROUND: Cefoxitin is active against some extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE), but has not been evaluated so far in the intensive care unit (ICU) settings. Data upon its pharmacokinetics (PK), tolerance and efficacy in critical conditions are scanty. We performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chabert, Paul, Provoost, Judith, Cohen, Sabine, Dupieux-Chabert, Céline, Bitker, Laurent, Ferry, Tristan, Goutelle, Sylvain, Richard, Jean-Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522958/ https://www.ncbi.nlm.nih.gov/pubmed/36175707 http://dx.doi.org/10.1186/s13613-022-01059-9

Ejemplares similares

Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint Infection
por: Cavalli, Zoé, et al.
Publicado: (2018)

Efficacy of cefoxitin for the treatment of urinary tract infection due to extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates
por: Senard, Olivia, et al.
Publicado: (2018)

Ampicillin/Sulbactam Vs. Cefoxitin for the Treatment of Pelvic Inflammatory Disease
por: Jemsek, Joseph G., et al.
Publicado: (1997)

Cefoxitin vs. Piperacillin/Tazobactam for Acute Appendicitis in Pediatric Patients
por: Paek, Hana, et al.
Publicado: (2017)

Role of SCCmec type in resistance to the synergistic activity of oxacillin and cefoxitin in MRSA
por: Reichmann, Nathalie T., et al.
Publicado: (2017)

Evaluation of in-house cefoxitin screening broth to determine methicillin-resistant staphylococci
por: Saenhom, Natkamon, et al.
Publicado: (2022)

Detection of Oxacillin/Cefoxitin Resistance in Staphylococcus aureus Present in Recurrent Tonsillitis
por: Messias, Aline Cristine Magalhães Costa, et al.
Publicado: (2023)

Single-Blind, Prospective, Randomized Study of Cefmetazole and Cefoxitin in the Treatment of Postcesarean Endometritis
por: Chatwani, Ashwin, et al.
Publicado: (1995)

Staphylococcus pseudintermedius’s PBP4 Is Directly Associated with the Dissociated Oxacillin and Cefoxitin Phenotype
por: Gagetti, Paula, et al.
Publicado: (2021)

Cefoxitin versus carbapenems as definitive treatment for extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteremia in intensive care unit: a propensity-matched retrospective analysis
por: Dequidt, Tanguy, et al.
Publicado: (2023)

Predictive performance of pharmacokinetic models for target concentration‐controlled infusion of cefoxitin as a prophylactic antibiotic in patients with colorectal surgery
por: Kang, Hyun‐Uk, et al.
Publicado: (2022)

Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production
por: Shi, Weifeng, et al.
Publicado: (2013)

Inpatient Treatment for Uncomplicated and Complicated Acute Pelvic Inflammatory Disease: Ampicillin/Sulbactam Vs. Cefoxitin
por: Hemsell, David L., et al.
Publicado: (1993)

Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing
por: Kalluri, Hari V., et al.
Publicado: (2020)

Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease
por: Haggerty, C L, et al.
Publicado: (2008)

Probiotic disruption of quorum sensing reduces virulence and increases cefoxitin sensitivity in methicillin-resistant Staphylococcus aureus
por: Cella, Monica Angela, et al.
Publicado: (2023)

Genomic Basis of Occurrence of Cryptic Resistance among Oxacillin- and Cefoxitin-Susceptible mecA-Positive Staphylococcus aureus
por: Liang, Bingshao, et al.
Publicado: (2022)

Gold Nanoparticle-Based Resuscitation of Cefoxitin against Clinical Pathogens: A Nano-Antibiotic Strategy to Overcome Resistance
por: Alafnan, Ahmed, et al.
Publicado: (2022)

Cefoxitin versus piperacillin–tazobactam as surgical antibiotic prophylaxis in patients undergoing pancreatoduodenectomy: protocol for a randomised controlled trial
por: Nevarez, Nicole M, et al.
Publicado: (2021)

Evaluation of the Occurrence of Staphylococcaceae with Reduced Susceptibility to Cefoxitin in Wild Ungulates in Brandenburg, Germany, Based on Land Use-Related Factors
por: Mateus-Vargas, Rafael H., et al.
Publicado: (2022)

Reviving the role of mecillinam against extended spectrum beta-lactamase producing enterobacterales
por: Kaleem, Fatima, et al.
Publicado: (2022)

2422. Efficacy of Cefoxitin for the Treatment of Urinary Tract Infection (UTI) Due to ESBL-Producing E. coli and K. pneumoniae Isolates
por: Senard, Olivia, et al.
Publicado: (2018)

A Whole-Genome Sequencing Approach To Study Cefoxitin-Resistant Salmonella enterica Serovar Heidelberg Isolates from Various Sources
por: Edirmanasinghe, Romaine, et al.
Publicado: (2017)

Experimental design and data on the adsorption and photocatalytic properties of boron nitride/cadmium aluminate composite for Cr(VI) and cefoxitin sodium antibiotic
por: Kumar, Rajeev, et al.
Publicado: (2019)

The Antimicrobial Activity of Micron-Thin Sol–Gel Films Loaded with Linezolid and Cefoxitin for Local Prevention of Orthopedic Prosthesis-Related Infections
por: Toirac, Beatriz, et al.
Publicado: (2023)

Treatment duration of complicated urinary tract infections by extended-spectrum beta-lactamases producing enterobacterales
por: Álvarez Otero, Judith, et al.
Publicado: (2020)

Colonization dynamics of extended-spectrum beta-lactamase-producing Enterobacterales in the gut of Malawian adults
por: Lewis, Joseph M., et al.
Publicado: (2022)

Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacterales in healthy Spanish schoolchildren
por: López-Siles, Mireia, et al.
Publicado: (2023)

Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection
por: Goutelle, Sylvain, et al.
Publicado: (2021)

Detection of colonisation by extended-spectrum beta-lactamase or carbapenemase producing Enterobacterales from frozen stool specimens
por: Tan, Pisey, et al.
Publicado: (2020)

Extended-Spectrum Beta-Lactamase-Producing and Carbapenem-Resistant Enterobacterales in Companion and Animal-Assisted Interventions Dogs
por: Roscetto, Emanuela, et al.
Publicado: (2021)

Fecal Carriage and Epidemiology of Extended-Spectrum Beta-Lactamase/Carbapenemases Producing Enterobacterales Isolates in Bulgarian Hospitals
por: Markovska, Rumyana, et al.
Publicado: (2021)

Epidemiology of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacterales in US children, 2016–2020
por: Grome, Heather, et al.
Publicado: (2023)

Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study
por: Ferry, Tristan, et al.
Publicado: (2021)

A Cross-Sectional Cohort Study of Extended-Spectrum-Beta-Lactamase-Producing Enterobacterales in Patients with Traveler's Diarrhea
por: Ljungquist, Oskar, et al.
Publicado: (2020)

Dynamics of extended-spectrum beta-lactamase-producing Enterobacterales colonization in long-term carriers following travel abroad
por: Armand-Lefèvre, Laurence, et al.
Publicado: (2021)

Analysis of Extended Spectrum Beta Lactamase (ESBL) Genes of Non-Invasive ESBL Enterobacterales in Southeast Austria in 2017
por: Paulitsch-Fuchs, Astrid H., et al.
Publicado: (2022)

Retrospective analysis of bacteraemia due to extended-spectrum beta-lactamase-producing Enterobacterales: the challenge of healthcare-associated infections
por: Peri, Anna Maria, et al.
Publicado: (2023)

Optimization of Empirical Antimicrobial Therapy in Enterobacterales Bloodstream Infection Using the Extended-Spectrum Beta-Lactamase Prediction Score
por: Haimerl, Brian J., et al.
Publicado: (2023)

Colonization of patients hospitalized at orthopedic department of tertiary hospital in Uganda with extended-spectrum beta-lactamase-producing enterobacterales
por: Bizimana, Jules, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_akibtume11aaf5dudk14g5l8s8